IDH1/2 mutations in acute myeloid leukemia

The mutational and epigenetic landscape of acute myeloid leukemia (AML) has become increasingly well understood in recent years, informing on biological targets for precision medicine. Among the most notable findings was the recognition of mutational hot-spots in the isocitrate dehydrogenase (IDH) g...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Ja Min, Yoo, Seung-Joo, Kim, Hyeong-Joon, Ahn, Jae-Sook, Koh, Youngil, Jang, Jun Ho, Yoon, Sung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958365/
https://www.ncbi.nlm.nih.gov/pubmed/35197370
http://dx.doi.org/10.5045/br.2021.2021152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958365/
https://www.ncbi.nlm.nih.gov/pubmed/35197370
http://dx.doi.org/10.5045/br.2021.2021152

Ejemplares similares